At a Glance
Standard Glass Lining Technology (SGLTL) delivered Q1 FY26 with ₹178 Cr revenue (+23.6% YoY) and ₹21 Cr PAT (+37.6% YoY). Margins held at a neat 17% OPM, while the stock climbed to ₹187. The company is opening shop in Southeast Asia and a US subsidiary – clearly trying to prove that their glass equipment isn’t just for domestic pharma labs.
Introduction
This IPO darling manufactures glass-lined equipment for the pharma and chemical sectors. Think of them as the unsung heroes keeping reactors from exploding – literally. Investors, however, are watching rising working capital days like a hawk; at 272 days, SGLTL is practically financing customer vacations.
Business Model (WTF Do They Even Do?)
- Products: Glass-lined reactors, storage tanks, and custom-engineered equipment.
- Clients: Pharmaceutical and chemical majors across India.
- Services: End-to-end solutions – design, assembly, installation.
Roast: They sell shiny industrial cookware to pharma companies, charge a premium, and somehow keep growing.
Financials Overview
Q1 FY26:
- Revenue: ₹178 Cr (+23.6% YoY)
- EBITDA: ₹30 Cr (OPM ~17%)
- Net Profit: ₹21 Cr (+37.6% YoY)
- EPS: ₹1.05
Commentary: Strong growth, stable margins, and a PAT that refuses to stay small.
Valuation
- CMP: ₹187
- EPS (TTM): ₹3.7 → P/E = 53x
